HALEON PLC (HLN)
NYSEHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-05
$9.15-0.87%
Close 2026-11-05 · 1-day change
NYSEHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-05
QuarterlyIQ Insights · HLN
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
No current thesis-health read is available for this company.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Model as of 2026-11-05 · Compared with 12 industry peers · Company calendar date is not available
Why it matters: If revenue growth is below the average, Haleon may slow down.
Worry ifHaleon's revenue growth falls below the median growth rate of its peers.
Less concerning ifRevenue growth remains at or above the median growth rate.
Why it matters: The update is the next named test of Haleon’s results. Look for reported sales growth and any change to its outlook.
Watch forThe 29 October update reports sales growth. It keeps or raises the company’s outlook.
Also watch forThe update reports falling sales or cuts the company’s outlook.
Why it matters: A drop in revenue growth would signal a weakening trend in Haleon's performance. This could impact investor confidence.
Worry ifQ2 revenue growth reported below the median growth rate for the sector.
Less concerning ifQ2 revenue growth remains at or above the median growth rate for the sector.
Why it matters: If revenue growth picks up, it signals stronger demand and market position. This could improve investor confidence.
Supportive ifRevenue growth speeds up to over 10% compared to last year.
Worry ifRevenue growth stays below 9% year over year.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$100 on $10,000 · ±1.0% | How much price usually moves either way. |
| Bad day | $225 loss on $10,000 · 2.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,295 loss on $10,000 · 22.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: If Haleon can improve its performance relative to strong peers like JNJ and UNH, it may boost investor confidence.
Watch forHaleon reports revenue growth that outpaces JNJ and UNH in the next quarter.
Also watch forHaleon's revenue growth lags behind JNJ and UNH for two consecutive quarters.
Why it matters: If revenue growth picks up, it could signal a positive change in Haleon's market position.
Supportive ifHaleon's revenue growth exceeds 10% year over year in Q3.
Worry ifRevenue growth remains below 10% year over year in Q3.
Why it matters: If Haleon's sector does better, it may show a good market for Haleon.
Supportive ifHealth Care sector outperforms the S&P 500 by more than 5% over the next quarter.
Worry ifHealth Care sector underperforms the S&P 500 by more than 5% over the next quarter.
Why it matters: If sector growth slows, it may impact Haleon's sales. This could reflect broader market challenges.
Worry ifSector revenue growth drops below 8% year over year.
Less concerning ifSector revenue growth stays above 8% year over year.
Why it matters: Higher revenue growth would show that Haleon is doing better. This might mean better market conditions or successful product plans.
Supportive ifQ3 revenue growth reported above 9% year over year.
Worry ifQ3 revenue growth remains below 9% year over year.
Why it matters: The consumer price index affects consumer spending. Changes here can impact Haleon's sales outlook.
Watch forCPI shows an increase greater than 0.5% month over month.
Also watch forCPI shows a decrease or increase less than 0.5% month over month.
Why it matters: The sector is in a maturing phase, with growth slowing. A rebound in revenue growth would point to a stronger sector trend.
Supportive ifThe sector’s three-year revenue growth moves back toward its prior highs from near 9%.
Worry ifThe sector’s three-year revenue growth falls further below its current level near 9%.